menu
The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis
The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step.

Roots Analysis is pleased toannounce the publication of its recent study, titled, “Continuous ManufacturingMarket (Small Molecules andBiologics), 2020 – 2030.”

 

The report features an extensivestudy of the current market landscape and future opportunities for companieswith capabilities in continuous manufacturing (both innovator companies within-house expertise and contract manufacturers). It features an in-depthanalysis, highlighting the capabilities of various stakeholders engaged in thisdomain. In addition to other elements, the study includes:

§  A  detailed assessment of the overall landscapeof companies with capabilities for continuous manufacturing

§ Elaborate profiles ofsome of the key contract manufacturers active in the pharmaceutical andbiopharmaceutical continuous manufacturing market

§ An analysis of thevarious partnerships related to continuous manufacturing, which have been establishedsince 2013

§ An analysis of theexpansions related to continuous manufacturing, which have been establishedsince 2013

§ An estimate of theglobal, continuous manufacturing capacity, based on the capacities of variousindustry stakeholders (as available on their respective company websites).

§ A study of thevarious grants that have been awarded to research institutes engaged inprojects related to continuous manufacturing, between 2014 and 2019

§ An in-depth analysisof the various patents that have been filed / granted related to continuousmanufacturing till 2019

§ Initiatives taken bythe leading pharmaceutical companies (in terms of revenues), covering bothpartnered as well as in-house projects.

§ A review of thecompanies offering modular facilities / modular cleanrooms

§ A case study of thecompanies offering technologies / equipment

§ A case study on theroadmap for the adoption of continuous manufacturing technique

§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)

§ Purpose ofManufacturing

§ In-House

§ Contract service

§ Scale of Operation

§ Commercial

§ Preclinical / Clinical

§ Type of ContinuousManufacturing related Service

§ API Manufacturing

§ End Product manufacturing

§ Type of Drug Molecule

§ Biologic

§ Small Molecule

§ Type of dosage form

§ Solid

§ Liquid

§ Key Geographical Regions

§  North America

§  Europe

§  Asia Pacific

 

§ Transcripts ofinterviews held with the following senior level representatives of stakeholdercompanies

§ Andrea Adamo, Founder and Chief Executive Officer, ZaiputFlow technologies

§ Bayan Takizawa, Co-Founder and Chief Business Officer,CONTINUUS Pharmaceuticals

§ Nick Thomson, Senior Director Chemical Research andDevelopment, Pfizer

§ Himanshu Gadgil, Director and Chief Scientific Officer,Enzene Biosciences

§ Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)

§ Ian Houson, Technical Project Manager, ContinuousManufacturing and Crystallization, University of Strathclyde

 

Keycompanies covered in the report

§ AbbVie Contract Manufacturing

§ Ajinomoto Bio-Pharma Services

§ Almac

§ Boehringer Ingelheim BioXcellence

§ Cambrex

§ CordonPharma

§ Hovione

§ Kaneka

§ Lonza

§ Patheon

§ SK biotek

§ WuXi AppTec

 

Formore information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html

 

Other Offerings

1.    PharmaceuticalContract Manufacturing Market (2nd Edition), 2018-2028

2.    BiopharmaContract Manufacturing Market (3rd Edition), 2019 - 2030

3.    ChinaPharmaceutical Contract Manufacturing Services Market, 2020-2030

4.    ChinaBiopharmaceutical Contract Manufacturing Market, 2020 -2030

 

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com